(Q24246590)

5

object named as

Thierry Poynard

0 references

author name string

Martin Thyge Mellerup

1

0 references

Kim Krogsgaard

2

0 references

Philippe Mathurin

Cochrane Database of Systematic Reviews

3

0 references

publication date

20 July 2005

0 references

published in

0 references

cites work

Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis. A randomized, controlled trial

1 reference

Crossref

https://api.crossref.org/works/10.1002%2F14651858.CD000345.PUB2

Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2F14651858.CD000345.PUB2

A controlled trial of interferon with or without prednisone priming for chronic hepatitis B

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2F14651858.CD000345.PUB2

HLA class I antigen expression as a measure of response to antiviral therapy of chronic hepatitis B

21 January 2018

1 reference

12 December 2020

Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals

1 reference

12 December 2020

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

1 reference

12 December 2020

Prolonged and high dose recombinant interferon alpha-2b alone or after prednisone priming accelerates termination of active viral replication in children with chronic hepatitis B infection

1 reference

12 December 2020

Effects of prednisolone pretreatment in interferon alfa therapy for patients with chronic non-A, non-B (C) hepatitis.

1 reference

12 December 2020

Safety and efficacy of interferon alpha-2b following prednisone withdrawal in the treatment of chronic viral hepatitis B. A case-controlled, randomised study

1 reference

12 December 2020

Treatment of chronic type B hepatitis in Southeast Asia

1 reference

12 December 2020

Treatment of chronic hepatitis B in children with prednisone followed by alfa-interferon: a controlled randomized study.

1 reference

12 December 2020

Olone modulates the therapeutic effect of interferon to eliminate preferentially the hepatitis B virus precore stop mutant

1 reference

12 December 2020

Autoantibody prevalence in chronic hepatitis B virus infection: effect in interferon alfa.

1 reference

12 December 2020

Prednisolone withdrawal therapy enhances the effect of human lymphoblastoid interferon in chronic hepatitis B. INTERPRED Trial Group

1 reference

12 December 2020

Randomized, double-blind, placebo-controlled trial of oromucosal low-dose interferon following prednisone withdrawal for chronic hepatitis B infection in Filipino patients

1 reference

12 December 2020

The treatment effect of alpha interferon in chronic hepatitis B is independent of pre-treatment variables. Results based on individual patient data from 10 clinical controlled trials. European Concerted Action on Viral Hepatitis (Eurohep).

1 reference

12 December 2020

Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B

1 reference

12 December 2020

Effect of recombinant alpha 2 interferon with or without prednisone in Chinese HBsAg carrier children.

1 reference

12 December 2020

Treatment of children with chronic hepatitis B with a combination of steroids and human lymphoblastoid interferon

1 reference

12 December 2020

Efficacy of interferon alfa-2b with or without prednisone withdrawal in the treatment of chronic viral hepatitis B. A prospective double-blind Belgian-Dutch study

1 reference

12 December 2020

Long-term effect of interferon alpha alone or after prednisone withdrawal in chronic hepatitis B. Interim report and review of the literature.

1 reference

12 December 2020

Effects of prednisolone/azathioprine in chronic hepatitis B viral infection

1 reference

12 December 2020

[Comparison of 2 treatment strategies with prednisone and interferon in chronic hepatitis B].

1 reference

12 December 2020

Prednisone-interferon combination in the treatment of chronic hepatitis B: direct and indirect metanalysis.

1 reference

12 December 2020

Recombinant interferon-alpha-2A with or without steroid pretreatment in children with chronic hepatitis B

1 reference

12 December 2020

Effects of antiviral agents on chronic hepatitis B. Analysis using Cox proportional hazard model

1 reference

12 December 2020

Dual-centre, double-blind, randomised trial of lymphoblastoid interferon alpha with or without steroid pretreatment in children with chronic hepatitis B

1 reference

12 December 2020

A pilot study on the effects of prednisone withdrawal on serum hepatitis B virus DNA and HBeAg in chronic active hepatitis B.

1 reference

12 December 2020

Do certain countries produce only positive results? A systematic review of controlled trials

1 reference

12 December 2020

Treatment of hepatitis B surface antigen carriers in the early stage of the infection using recombinant alpha-interferon with steroid priming

1 reference

12 December 2020

Randomised controlled trial of lymphoblastoid interferon alfa in Europid men with chronic hepatitis B virus infection

1 reference

12 December 2020

LONG-TERM FOLLOW-UP IN A RANDOMISED CONTROLLED TRIAL OF RECOMBINANT α2-INTERFERON IN CHINESE PATIENTS WITH CHRONIC HEPATITIS B INFECTION

1 reference

12 December 2020

Short report: prednisolone withdrawal followed by lymphoblastoid interferon in the therapy of adult patients with presumed childhood-acquired chronic hepatitis B virus infection

1 reference

12 December 2020

Prospective randomized controlled trial of sequential treatment with corticoids and alpha-interferon versus treatment with interferon alone in patients with chronic active hepatitis B

1 reference

12 December 2020

Efficacy of steroid withdrawal and low-dose interferon treatment in chronic active hepatitis B. Results of a randomized multicenter trial. Swiss Association for the Study of the Liver

1 reference

12 December 2020

Lymphoblastoid interferon alfa with or without steroid pretreatment in children with chronic hepatitis B: a multicenter controlled trial

1 reference

12 December 2020

Hepatitis B infection: pathogenesis and management

1 reference

12 December 2020

Rapid withdrawal of immunosuppressive therapy in chronic active hepatitis B infection

1 reference

12 December 2020

Interferon-alpha2b therapy is efficacious in Asian-Americans with chronic hepatitis B infection: a prospective controlled trial

1 reference

12 December 2020

Recombinant leukocyte a interferon treatment in patients with chronic hepatitis B virus infection. Pharmacokinetics, tolerance, and biologic effects

1 reference

12 December 2020

Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B

1 reference

12 December 2020

Beneficial effect of prednisolone withdrawal followed by human lymphoblastoid interferon on the treatment of chronic type B hepatitis in Asians: a randomized controlled trial

1 reference

12 December 2020

Effect of prednisone priming followed by alfa-interferon in treatment of children with chronic hepatitis B: an interim analysis of a controlled trial

1 reference

12 December 2020

A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group

1 reference

12 December 2020

Alpha-interferon treatment in Chinese patients with chronic hepatitis B.

1 reference

12 December 2020

Recombinant interferon alfa-2b following prednisone withdrawal in the treatment of chronic type B hepatitis

1 reference

12 December 2020

1 reference

12 December 2020

Prednisolone withdrawal followed by recombinant alfa-interferon in chronic non-A, non-B hepatitis: interim results of a randomized controlled trial

1 reference

12 December 2020

Treatment of chronic hepatitis B with interferon alpha (Wellferon) with and without previous corticosteroid therapy -- results of a multicenter, double blind study

1 reference

12 December 2020

A controlled trial of human lymphoblastoid interferon in chronic hepatitis B in Italy

1 reference

12 December 2020

A controlled trial of high dose interferon, alone and after prednisone withdrawal, in the treatment of chronic hepatitis B: long term follow up

1 reference

12 December 2020

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

1 reference

12 December 2020

Treatment of chronic hepatitis B virus infection in special groups of patients: decompensated cirrhosis, immunosuppressed and paediatric patients

1 reference

12 December 2020